FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
23 letters match. Newest first.
-
DrugsKellin Chemicals Co., Ltd. - Zhangjiagang
Kellin Chemicals' API site refused FDA inspection, so FDA calls its drugs adulterated.
High risk -
DrugsSafrel Pharmaceuticals LLC
FDA warned Safrel Pharmaceuticals, an OTC drug labeler in Dayton, New Jersey, that it lacked quality oversight of its suppliers and shipped adulterated drugs.
High risk -
DrugsAva Inc.
FDA warned Ava Inc. about adulterated drugs after an inspection found data-integrity failures and hidden trial injections in its Willowbrook, Illinois lab.
High risk -
DrugsCosmetic Manufacturers Pty Ltd.
FDA warned Cosmetic Manufacturers Pty Ltd. that its Australian drug site was adulterated due to CGMP violations and placed its drugs on import alert.
High risk -
DrugsDarmerica, LLC
FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.
High risk -
DrugsKenil Healthcare Private Limited
FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.
High risk -
DrugsAACE Pharmaceuticals, Inc.
AACE Pharmaceuticals distributed adulterated Lubricant PM Ointment made by CMO Brassica with CGMP violations and failed supplier qualification.
High risk -
AnimalEvolution Pets LLC
Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.
High risk -
AnimalNutrition Strength Ltd.
FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.
High risk -
DrugsLS Promotions Inc.
LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.
High risk -
AnimalBullyKamp Products LLC
BullyKamp Products LLC marketed unapproved animal drugs with disease-treatment claims on its website, FDA says.
High risk -
DrugsVelocity Pharma LLC
Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.
High risk -
DrugsNatco Pharma Limited
FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.
High risk -
DrugsEzriCare LLC
EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.
High risk -
DrugsDelsam Pharma LLC
Delsam Pharma distributed non-sterile, contaminated artificial tears and eye ointment made by its contract manufacturer, FDA found.
High risk -
DrugsMei Lan Thailand Co., Ltd.
Mei Lan Thailand, an API drug manufacturer, refused an FDA inspection and was placed on Import Alert 55-03.
High risk -
DrugsSudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi
FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.
High risk -
DrugsTRP Company, Inc
FDA warns TRP Company that its homeopathic eye drops and ointments are unapproved new drugs and may be adulterated.
High risk -
AnimalSouth Pork Ranch Equipment LLC
South Pork Ranch Equipment marketed unapproved Cydectin and Blackstrap animal drugs for treating disease in goats, sheep, and cattle online.
High risk -
AnimalFirst Strike Pet Products
First Strike Pet Products sold unapproved flea, tick, and dewormer animal drugs online, FDA says.
High risk -
DrugsBi-Coastal Pharma International
FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.
High risk -
DrugsFrozen Wheels, LLC
Frozen Wheels tried to import hand sanitizers labeled with ethanol that FDA testing found contained methanol or undeclared isopropanol.
High risk -
DrugsProfessional Compounding Centers of America dba PCCA
PCCA received adulterated drug ingredients from suppliers on FDA import alerts and failed adequate glycerin identity testing.
High risk